Results 111 to 120 of about 1,633 (196)

Impact of the Tumor Microenvironment and Molecular Oncology in Peritoneal Metastases. [PDF]

Cancers (Basel)
Khurshid A, Chalasani HS, Jacobs A, Kasakewitch JP, Avila K, Brown ZJ.   +5 more
europepmc   +1 more source

Integrating artificial intelligence and in-silico modeling to redefine therapeutic strategies for peritoneal seeding: A disulfiram repurposing concept. [PDF]

Pak J Med Sci
Yang J, Park JE, Han S.
europepmc   +1 more source

Peritoneal metastasis in pancreatic cancer: molecular mechanisms, microenvironmental remodeling, and emerging intraperitoneal interventions. [PDF]

Front Mol Biosci
Chen J, Li K, Zou Y, Yang J, Xing L, Xiao K.   +5 more
europepmc   +1 more source

Regional Therapies Utilized in Treating Unresectable Colorectal Adenocarcinoma with Peritoneal Metastases. [PDF]

Cancers (Basel)
Malik S, Le V, Dayyani F, Senthil M, Eng OS, O'Leary MP.   +5 more
europepmc   +1 more source

Population pharmacokinetics and pharmacodynamics of intraperitoneal aerosolized nanoparticle albumin-bound paclitaxel (nab-PTX) and metabolites. [PDF]

Br J Clin Pharmacol
De Sutter PJ, Sandra L, Van Ovost J, Van de Sande L, Graversen M, Mortensen MB, Cosyns S, Hoorens A, Willaert W, Ceelen W, Vermeulen A.   +10 more
europepmc   +1 more source

Neoadjuvant Pressurized Intraperitoneal Aerosol Chemotherapy for Conversion to Cytoreductive Surgery in Unresectable Malignant Peritoneal Mesothelioma: A Report of 2 Cases. [PDF]

Am J Case Rep
Urbano-Ruiz A, Latronico Palma B, Carnut Rego RE, Bianqui Guaraldo da Silva D, Fava B, Araujo Falcão E, Rodrigues Barbosa da Silva ML, Rodrigues Leandro Uliano J.   +7 more
europepmc   +1 more source

Normothermic Intraperitoneal and Systemic Treatment (NIPS) Using Paclitaxel for Peritoneal Metastases from Gastrointestinal Cancer. [PDF]

Cancers (Basel)
Kitayama J.
europepmc   +1 more source

Underutilization of CRS, HIPEC & PIPAC in peritoneal mesothelioma across a German nationwide cohort. [PDF]

World J Surg Oncol
Müller V, Hornung M, Werner J, Schlitt HJ, Acs M.   +4 more
europepmc   +1 more source

The Role of Inflammatory Biomarkers in PIPAC: Predicting Survival and Treatment Completion in Patients with Peritoneal Metastasis. [PDF]

J Cancer
Roensholdt S, Graversen M, Detlefsen S, Fristrup C, Pfeiffer P, Mortensen MB.   +5 more
europepmc   +1 more source

Absolute Bioavailability of Oxaliplatin After Intraperitoneal Administration by Electrostatic Pressurized Intraperitoneal Aerosol Chemotherapy (ePIPAC): Systemic Pharmacokinetics of the CRC-PIPAC-II Trial. [PDF]

Ann Surg Oncol
van den Heuvel TBM, Rauwerdink P, Hulshof E, van de Vlasakker VCJ, Moes DJAR, Pluimakers G, Rovers KPB, Creemers GJ, Burger PJWA, Nienhuijs SW, Wiezer RJ, Lurvink RJ, Boerma D, De Hingh IHJT, Deenen MJ.   +14 more
europepmc   +1 more source